The role of FOXP3 in non-small cell lung cancer and its therapeutic potentials
Jia Peng(Chinese University of Hong Kong), George G. Chen(Chinese University of Hong Kong), Shucai Yang(Southern Medical University Shenzhen Hospital), Calvin S.H. Ng(Johnson & Johnson (United States))
Cited by 18
Related Papers
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
|Molecular Cancer|2017|429
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358
Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
|Journal of Clinical Oncology|2016|245
New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2017|197